XML 16 R4.htm IDEA: XBRL DOCUMENT v3.20.4
Unaudited Condensed Consolidated Statements Of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Jan. 31, 2021
Jan. 31, 2020
Revenue:    
Total revenue $ 970,321 $ 834,381
Cost of revenue:    
Amortization of intangible assets 11,886 13,169
Total cost of revenue 207,999 192,868
Gross margin 762,322 641,513
Operating expenses:    
Research and development 357,468 314,283
Sales and marketing 170,628 152,855
General and administrative 77,488 68,744
Amortization of intangible assets 8,390 9,364
Restructuring charges 0 8,751
Total operating expenses 613,974 553,997
Operating income 148,348 87,516
Other income (expense), net 28,756 12,057
Income before income taxes 177,104 99,573
Provision (benefit) for income taxes 15,076 (4,488)
Net income 162,028 104,061
Net income (loss) attributed to non-controlling interest (317) 0
Net income attributed to Synopsys $ 162,345 $ 104,061
Net income per share:    
Basic (in USD per share) $ 1.06 $ 0.69
Diluted (in USD per share) $ 1.03 $ 0.67
Shares used in computing per share amounts:    
Basic (shares) 152,498 150,244
Diluted (shares) 157,277 154,504
Time-based products    
Revenue:    
Total revenue $ 631,290 $ 556,439
Cost of revenue:    
Cost of revenue 127,347 117,784
Upfront products    
Revenue:    
Total revenue 174,381 150,721
Maintenance and service    
Revenue:    
Total revenue 164,650 127,221
Cost of revenue:    
Cost of revenue $ 68,766 $ 61,915